Clinical trial
Linezolid for the Treatment of Infections Caused by Methicillin Resistant…
NCT00150332 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00150332 |
|---|---|
| Title | Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan |
| Official title | Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Nosocomial |
| Intervention type | Drug |
| Interventions | linezolid |
| Enrollment | 24 |
| Start date | Jan 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | May 10, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: